Dectova is indicated for the treatment of complicated and potentially life-threatening influenza A or B virus
infection in adult and paediatric patients (aged ≥6 months) when:
• The patient’s influenza virus is known or suspected to be resistant to anti-influenza medicinal products
other than zanamivir, and/or
• Other anti-viral medicinal products for treatment of influenza, including inhaled zanamivir, are not
suitable for the individual patient.